CleaRank Financial AI • AI-powered analysis using real-time market data from TwelveData
Analysis reviewed by Roger Wohlner, Financial Journalist. Data refreshed daily. Not financial advice.
Intuitive Surgical Inc. (ISRG) is trading at $420.24, above its 50-day SMA of $389.56 and 20-day EMA of $406.88, though below its 200-day SMA of $441.10. The company demonstrates strong fundamental performance with a 17.42% return on equity and a 28.45% net profit margin, significantly outperforming sector averages in profitability and revenue growth. Wall Street analysts maintain a consensus "Buy" rating with a median price target of $484, suggesting a 15.2% upside potential. Despite the positive outlook, significant insider selling totaling $127.6 million across recent filings presents a notable risk. The company's forward growth estimates remain solid, with projected revenue growth of 17% for the current year and 13% for the next, alongside an expected earnings per share of $10.80 for the current year and $12.11 for the next. These figures, combined with a strong technical momentum indicated by a bullish RSI, support a positive near-term outlook, though the heavy insider selling warrants close monitoring.
ISRG at a glance
Intuitive Surgical Inc. (ISRG): Buy, 74/100 on CleaRank's AI score.
TrendMixed: the price is above its 50-day but below its 200-day moving average ($389.56 and $441.10).
EarningsISRG beat estimates in 3 of its last 3 quarters, yet fell the next day after 2 of those beats.
InsidersInsiders sold $127.6M and made no open-market purchases over the last 18 months.
ValuationP/E of 48.4 against 31.9 for the Healthcare sector: a premium to peers (+52%).
As of October 15, 2026, Intuitive Surgical Inc. (ISRG) trades at $420.24. Wall Street's consensus target is $484.00 across 33 analysts. The 14-day RSI (daily closes) is 62, showing bullish momentum without being overbought, and the price is above its 50-day simple moving average of $389.56.
Figures as of October 15, 2026.
Only on CleaRank
Figures we compute ourselves from ISRG's own price, earnings and insider-filing history. Tap one to see it in context.
Trading at a significant premium to sector peers (+52%), suggesting market expectations for superior growth or market position.
ISRG Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
In the last 3 quarters, ISRG beat the analyst estimate 3 times; the stock fell in the first session after 2 of those beats.
ISRG earnings surprises and the stock's reaction
Report
EPS estimate
EPS actual
Surprise
First session
5 sessions
Jul 16, 2026
$2.50
$2.80
+12.00%
-14.15%
-17.48%
Apr 21, 2026
$2.11
$2.50
+18.48%
+7.16%
+3.40%
Jan 22, 2026
$2.27
$2.53
+11.45%
-0.35%
-3.47%
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
As of October 15, 2026, ISRG has beaten the analyst EPS estimate in 3 of its last 3 reported quarters and fell in the first trading session after 2 of those beats; its latest report, on July 16, 2026, came in 12.00% above the estimate and the stock moved -14.15% in the first session.
ISRG Analysis
Company's Health4/5
12-Month Analyst Target+15.17% above price
Median of 33 analysts (12-month)
$484.00
AI Analyst Consensus ScoreBuy
Intuitive Surgical Inc. (ISRG) is currently trading above its 50-day Simple Moving Average (SMA) of $389.56 and its 20-day Exponential Moving Average (EMA) of $406.88, indicating positive short-term momentum. However, the stock remains below its 200-day SMA of $441.10, suggesting a longer-term downtrend or consolidation phase. The 14-day Relative Strength Index (RSI) is at 62.13, signaling bullish momentum without being overbought. The MACD indicator is positive at 10.38, further supporting upward price action. Volume has been slightly above average recently, with the latest volume at 1.91 million compared to an average of 1.81 million. Key support levels are near the 50-day SMA, while resistance lies around the 200-day SMA and previous highs.
ProTips
Monitor insider selling activity closely, as the recent $127.6 million in dispositions could signal future headwinds.
The stock is trading below its 200-day SMA, suggesting caution for short-term traders until it can break above this key resistance level.
Given the premium valuation, consider position sizing carefully and look for opportunities to enter on pullbacks towards the 50-day SMA.
Key Catalysts
BullishContinued Market Leadership in Robotic Surgery
ISRG's established dominance in the robotic-assisted minimally invasive surgery market provides a strong foundation for sustained revenue growth and market share expansion.
Source: Industry Analysis
BullishPositive Earnings Surprises
The company has a consistent history of beating analyst earnings estimates, indicating operational efficiency and strong demand for its products.
Source: Earnings Reports
BearishPremium Valuation Metrics
ISRG trades at a high P/E ratio of 48.40 and P/S ratio of 13.51, significantly above sector averages, making it vulnerable to market corrections or negative sentiment.
Source: Fundamental Analysis
NeutralTrading Below 200-Day SMA
The stock's current position below its 200-day moving average indicates potential longer-term weakness or consolidation, requiring a break above this level for a more bullish technical outlook.
Source: Technical Analysis
Market Outlook
Intuitive Surgical Inc. (ISRG) is expected to see continued growth driven by its dominant position in the robotic surgery market and ongoing technological advancements. The company's strong profitability and lack of debt provide a solid foundation for future expansion. Potential catalysts for upside include further market penetration, new product introductions, and positive clinical trial results. Conversely, significant insider selling totaling over $127 million, a premium valuation, and increasing competition pose downside risks. A shift in healthcare policy or a broader market downturn could also impact ISRG's performance, making continued monitoring of insider activity and competition essential.
Key Statistics
Market Cap
148.46B
P/E Ratio
48.40
EPS (TTM)
8.72
Dividend Yield
0.00%
52 Week High
603.88
52 Week Low
328.57
As of October 15, 2026, ISRG trades at $420.24, with a market value of $148.46B and a P/E ratio of 48.40.
Intuitive Surgical Inc. (ISRG) exhibits strong profitability metrics, with a net profit margin of 28.45% and an operating margin of 33.60%, significantly exceeding the sector median of 6.9% for Return on Equity. Its Price-to-Sales ratio stands at 13.51, which is considerably higher than the sector median of 3.7, indicating a premium valuation. The company's debt-to-equity ratio is 0.00, signifying a very healthy balance sheet with no leverage. While the Price-to-Earnings ratio of 48.40 is high compared to the sector median P/E of 31.9, the company's strong revenue growth of 18.5% and strong earnings per share of $8.72 suggest that the premium valuation may be justified by its growth prospects. Analysts project continued revenue growth of 17% for the current year and 13% for the next.
Earnings & Growth Analysis
Intuitive Surgical Inc. (ISRG) has demonstrated a pattern of beating analyst earnings estimates, most recently reporting EPS of $2.80 for the quarter reported July 16, 2026, which was 12% above the estimate of $2.50. This follows a previous quarter where actual EPS of $2.50 exceeded estimates by 18.48%. While the earnings beat on July 16, 2026, was accompanied by a 14.15% price drop, the company has a history of positive earnings surprises.
Key Risks
A significant risk for Intuitive Surgical Inc. (ISRG) is the heavy insider selling, with $127.6 million in sales across recent filings. The stock's valuation also appears stretched, with a P/E ratio of 48.40 and a P/S ratio of 13.51, significantly higher than sector averages. Also, the stock is trading below its 200-day SMA, suggesting potential headwinds in its longer-term trend.
Technical Indicators i
RSI (14-day)
62.13
MACD (12, 26)
10.38
SMA (50-day)
389.56
SMA (200-day)
441.10
Technical RatingBullish
RSI
Bullish
SMA Cross
Bearish
Price vs SMA
Bullish
MACD
Bullish
Moving averages show a lagging Death Cross (50-day: $389.56, 200-day: $441.10), price sits above the 50-day SMA but below the 200-day SMA - a mixed posture.
As of October 15, 2026, with ISRG at $420.24, its 14-day RSI is 62.1 (showing bullish momentum without being overbought), its 50-day simple moving average is $389.56 and its 200-day is $441.10.
Calculated by CleaRank on daily closes as of October 15, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)+0.53
Moderate correlation
Nasdaq 100 (QQQ)+0.47
Moderate correlation
Bitcoin (BTC)+0.14
Weak correlation
Gold (XAU)+0.06
Weak correlation
As of October 15, 2026, ISRG's 1-year correlation of daily returns is +0.53 with S&P 500 (SPY), +0.47 with Nasdaq 100 (QQQ), +0.14 with Bitcoin (BTC) and +0.06 with gold (XAU).
Check Custom Correlation
How does any other asset move with ISRG? One year of daily closes, Pearson correlation.
Try
ISRG Wall Street View
12-month price targets
Low $324.00Median $484.00 (+15.2%)High $685.00
Ratings
Buy 25Hold 7Sell 13 months ago: 23 of 33 buy
Recent rating actions
Recent analyst rating actions on ISRG
Date
Firm
Action
Rating
Oct 7, 2026
Barclays
Initiates
Overweight
Sep 8, 2026
BTIG
Reiterates
Buy
Aug 12, 2026
Oppenheimer
Upgrade
Outperform
Jul 30, 2026
HSBC
Downgrade
Hold
Jul 28, 2026
UBS
Assumes
Buy
Jul 17, 2026
Raymond James
Maintains
Outperform
As of October 15, 2026, 33 Wall Street analysts cover ISRG: 25 rate it a buy or strong buy, 7 a hold and 1 a sell or strong sell. Their 12-month price targets range from $324.00 to $685.00, with a median of $484.00, 15.2% above the price of $420.24.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
ISRG Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative2%Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Long entry pick an entry style
Conservative
$411.84
2% below current price (Pullback entry)
Lower risk, wait for pullback
Aggressive
$420.24
Buy at current price
Higher risk, immediate entry
Risk Management
STOP LOSS
$395.65
MAX LOSS
-3.9%
Volatility-Adjusted Stop Loss
Calculated based on RSI (62.1) and current market volatility
These levels come from ISRG's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Growth of $10,000
A $10,000 investment in ISRG in October 2016 would be worth about $53,312 today, compared with about $36,237 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
ISRG Drawdowns & Recovery
Worst fall, last 10 years
-48.8%
November 2021 to October 2022
Recovery
15 months
back at the old peak by January 2024
From the 10-year high
-31.2%
highest close, January 2025
1-year holds that gained
75%
of every 1-year window
As of October 15, 2026, ISRG's worst peak-to-trough fall over the last 10 years was -48.8% (November 2021 to October 2022); it regained that peak by January 2024, 15 months after the low, and 75% of 1-year holding periods ended with a gain.
From weekly closing values. A drawdown is the fall from the highest value reached so far to a later low.
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ISRG today could grow to about $25,778 by 2036 in the base case, with a 90th-percentile outcome near $99,044 and a 10th-percentile outcome around $6,709. Projections are statistical simulations, not guarantees.
ISRG Stock Price Prediction: 2030
CleaRank's simulation projects a price near $614 for ISRG by 2030 in the base case, from $420 today (1.5x over 4 years). The 10th-percentile path ends near $262. These are outcomes of a Monte Carlo simulation run on ISRG's historical return distribution, not price targets, and they assume no dividends are reinvested.
ISRG simulated price paths by year
Year
10th percentile
Base case
90th percentile
2027
$302
$462
$707
2028
$278
$508
$927
2029
$267
$558
$1,167
2030
$262
$614
$1,438
2031
$260
$675
$1,748
Method: a lognormal simulation of ISRG's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
As of October 15, 2026, ISRG insiders reported 58 open-market sales worth $127.6M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
Recent insider transactions in ISRG
Date
Insider
Type
Shares
Value
Sep 15, 2026
WIDMAN FREDRIK
Officer
Sell
1.1K
$407.8K
Sep 15, 2026
WIDMAN FREDRIK
Officer
Option
1.1K
$102.9K
Sep 11, 2026
BROSIUS MARK PRESTON
Officer
Sell
48
$17.1K
Sep 9, 2026
BROSIUS MARK PRESTON
Officer
Sell
69
$24.7K
Aug 21, 2026
BROSIUS MARK PRESTON
Officer
Sell
154
$59.4K
Aug 19, 2026
BROSIUS MARK PRESTON
Officer
Sell
231
$90.8K
Aug 11, 2026
GUTHART GARY S
Director
Sell
10.0K
$4.0M
Aug 11, 2026
LADD AMY L
Director
Sell
472
$179.9K
Aug 10, 2026
LOEB GARY
Officer
Sell
400
$151.6K
Jul 31, 2026
BROSIUS MARK PRESTON
Officer
Sell
56
$19.5K
Page 1 of 1
Frequently Asked Questions
What are the key risks for Intuitive Surgical Inc. (ISRG)?
The primary risks for ISRG include substantial insider selling totaling $127.6 million, a high valuation with a P/E ratio of 48.40, and the stock trading below its 200-day moving average. Competitive pressures and potential regulatory changes in the healthcare sector also represent ongoing risks.
How does ISRG's financial health compare to its sector peers?
Intuitive Surgical Inc. (ISRG) demonstrates superior financial health compared to its Healthcare sector peers, particularly in profitability. Its net profit margin is 28.45% and return on equity is 17.42%, significantly higher than sector medians, and it carries no debt (debt-to-equity of 0.00).
What is the current analyst consensus for ISRG stock?
The current Wall Street consensus for ISRG is a 'Buy', supported by 33 analysts. Of these, 8 rate it a Strong Buy, 17 rate it a Buy, and 7 rate it a Hold, with only 1 Sell rating.
How has ISRG performed in recent earnings reports?
ISRG has a track record of beating analyst earnings estimates. Most recently, for the quarter reported July 16, 2026, the company reported EPS of $2.80, exceeding estimates by 12%. This follows a pattern of positive earnings surprises in prior quarters.
What is ISRG's long-term growth outlook?
The long-term outlook for ISRG appears positive, with analysts projecting revenue growth of 17% for the current year and 13% for the next. The company's strong market position in robotic surgery and ongoing innovation suggest sustained growth potential over the next five years, with an average annual growth estimate of 14.2%.
Is ISRG in an uptrend?
Not clearly. Intuitive Surgical Inc. (ISRG) trades at $420.24, above its 50-day but below its 200-day moving average ($389.56 and $441.10). Its 14-day RSI on daily closes is 62.1, showing bullish momentum without being overbought.
Are insiders buying or selling ISRG?
Selling, on balance. In the last 18 months, ISRG's officers, directors and large holders reported 58 sales worth $127.6M and no open-market purchases. Grants and option exercises are not counted as buying.
What is the analyst price target for ISRG?
As of October 15, 2026, the 33 Wall Street analysts covering ISRG have 12-month targets from $324.00 to $685.00, with a median of $484.00, 15.2% above the current price of $420.24. 25 rate it a buy or strong buy, 7 a hold and 1 a sell or strong sell. Three months ago 23 of 33 rated it a buy.
What is ISRG's biggest drop in the last 10 years?
Intuitive Surgical Inc. (ISRG)'s worst peak-to-trough fall over the last 10 years was -48.8%, from November 2021 to October 2022. It regained that peak by January 2024, 15 months after the low. Over the same period, 75% of 1-year holding periods ended with a gain.
What are ISRG's best and worst months?
Over the last 10 years, November has been ISRG's strongest month on average (+5.81%, rising in 8 of 10 years) and March its weakest (-1.39%, rising in 5 of 10 years). Seasonal averages describe the past and do not predict a given year.
